Onosma glomeratum Y. L. Liu polysaccharide alleviates LPS-induced pulmonary inflammation via NF-κB signal pathway
Qian Yang,Xuelian Shen,Junxi Zhao,Aga Er-bu,Xiaoxia Liang,Changliang He,Lizi Yin,Funeng Xu,Haohuan Li,Huaqiao Tang,Yuping Fu,Cheng Lv
DOI: https://doi.org/10.1016/j.ijbiomac.2024.130452
IF: 8.2
2024-03-02
International Journal of Biological Macromolecules
Abstract:As a traditional Chinese medicinal and edible homologous plant, Onosma glomeratum Y. L. Liu has been used for treating lung diseases in Tibet. In this study, a pectin polysaccharide, OGY -LLPA, with a molecular weight of 62,184 Da, was isolated and characterized by GC–MS and NMR analysis. It mainly consists of galacturonic acid (GalA), galactose (Gal), rhamnose (Rha), and arabinose (Ara), with a linear main chain of galacturonic acid (homogalacturonan, HG) inserted by part of rhamnose galacturonic acid (rhamnogalacturonan, RG), attaching with arabinogalactan (AG) branches at RG-I. Both in the LPS-induced A549 cell model and LPS-induced pneumonia mouse model, OGY -LLPA demonstrated strong anti-inflammatory effects, even comparable to DEX, indicating its potential as an anti-pneumonia candidate agent. Moreover, low-dose OGY -LLPA alleviated LPS-induced pulmonary inflammation by inhibiting the NF-κB signaling pathway. Overall, these findings could not only contribute to the utilization of Onosma glomeratum Y. L. Liu., but also provides a theoretical basis for the treatment of inflammation-related diseases.
polymer science,biochemistry & molecular biology,chemistry, applied